Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Winning cash for taking blood pressure meds increases compliance
About 71% of patients in the rewards group opened their blood pressure medication on 80% of days, compared with about 34% in the control group.
Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial
The LANDMARK trial continues to show positive outcomes for the TAVR valve made in India.
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.
SCAI: To improve cardiogenic shock outcomes, reduce lactate levels
SCAI feels this is the best way forward to try lowering mortality rates, but the group is asking cardiologists to help by gathering more data.
Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO
The agreement also will make Boston Scientific the exclusive distributor for the new ICE catheter optimized for left atrial appendage occlusion workflows.

Athletes more likely to develop AFib

There was no significant difference when the athlete had diabetes or hypertension.

New spray could help heal the body after a heart attack

Unhappy with existing methods for delivering stem cells to the heart, a team of researchers has developed an exosome solution that can be sprayed through a tiny incision.

Cardiologists sound alarm on ongoing methamphetamine epidemic

Methamphetamine-related heart failure hospitalizations increased 585% from 2008 to 2018, researchers found.

CVS: Pandemic influenced personal health improvements

The COVID-19 pandemic has led many people to take control of their health, according to the 2021 Health Care Insights Survey from CVS Health.

RSNA’s $30M policy did not insure against COVID-19 cancellation, judge rules

The society was seeking coverage for losses related to last year's annual meeting, but a federal judge said the event insurance clearly excluded communicable diseases.

Bayer's big news: Finerenone gains FDA approval for patients with chronic kidney disease, type 2 diabetes

The medication is approved for slowing CKD progression in patients with type 2 diabetes. It can also reduce a patient's risk of heart failure hospitalization and cardiovascular death.

Imaging technique could help predict heart rhythm issues among COVID-19 patients

"This is a safe and affordable new data point that can clue us in about who might develop atrial fibrillation," one researcher said.

Additional experience pays off when performing endovascular treatments

Researchers tracked the outcomes of more than 4,500 procedures performed over five years, sharing their findings in Stroke.

Clinical

Winning cash for taking blood pressure meds increases compliance

Myval TAVR valve outperforms Sapien and Evolut in the late-breaking LANDMARK trial

New physician Medicare payments for the Agent drug-coated balloon set for 2027

SCAI: To improve cardiogenic shock outcomes, reduce lactate levels

Siemens Healthineers and Boston Scientific partner on next-generation intracardiac echo for LAAO